* Ingevity Corp NGVT.N reported quarterly adjusted
earnings of
$1.10 per share for the quarter ended September 30, lower than
the same quarter last year, when the company reported EPS of
$1.21. The mean expectation of four analysts for the quarter
was for earnings of 90 cents per share. Wall Street expected
results to range from 60 cents to $1.15 per share.
* Revenue fell 15.5% to $376.90 million from a year ago;
analysts
expected $384.28 million.
* Ingevity Corp's reported EPS for the quarter was a loss of
$2.95.
* The company reported a quarterly loss of $107.2 million.
* Ingevity Corp shares had fallen by 8.4% this quarter and
lost 24.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 26.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the diversified
chemicals peer group is also "buy"
Wall Street's median 12-month price target for Ingevity Corp is
$46.50
This summary was machine generated from LSEG data October 30 at
03:15 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.90 1.10 Beat
Jun. 30 2024 1.05 1.01 Missed
Mar. 31 2024 0.32 0.52 Beat
Dec. 31 2023 -0.19 0.21 Beat